FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

4/21/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   4/21/2017     P    1000   A $0.058   20270949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20271949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20272949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20273949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20274949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20275949   D    
Common Stock   4/21/2017     P    2000   A $0.058   20277949   D    
Common Stock   4/21/2017     P    2000   A $0.058   20279949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20280949   D    
Common Stock   4/21/2017     P    1000   A $0.059   20281949   D    
Common Stock   4/21/2017     P    1000   A $0.059   20282949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20283949   D    
Common Stock   4/21/2017     P    1000   A $0.058   20284949   D    
Common Stock   4/21/2017     P    1000   A $0.0645   20285949   D    
Common Stock   4/21/2017     P    1000   A $0.0645   20286949   D    
Common Stock   4/21/2017     P    1000   A $0.0627   20287949   D    
Common Stock   4/21/2017     P    1000   A $0.062   20288949   D    
Common Stock   4/21/2017     P    1000   A $0.0618   20289949   D    
Common Stock   4/21/2017     P    1000   A $0.0643   20290949   D    
Common Stock   4/21/2017     P    2000   A $0.0643   20292949   D    
Common Stock   4/21/2017     P    1000   A $0.0645   20293949   D    
Common Stock   4/21/2017     P    1000   A $0.0645   20294949   D    
Common Stock   4/21/2017     P    1000   A $0.065   20295949   D    
Common Stock   4/21/2017     P    1000   A $0.0646   20296949   D    
Common Stock   4/21/2017     P    1000   A $0.069   20297949   D    
Common Stock   4/21/2017     P    1000   A $0.0688   20298949   D    
Common Stock   4/21/2017     P    1000   A $0.068   20299949   D    
Common Stock   4/21/2017     P    1000   A $0.069   20300949   D    
Common Stock   4/21/2017     P    1000   A $0.0678   20301949   D    
Common Stock   4/21/2017     P    1000   A $0.0678   20302949   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 4/24/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.